360 related articles for article (PubMed ID: 30338663)
1. Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway.
Liu Y; Gao S; Zhu J; Zheng Y; Zhang H; Sun H
Cancer Med; 2018 Nov; 7(11):5704-5715. PubMed ID: 30338663
[TBL] [Abstract][Full Text] [Related]
2. Dihydroartemisinin regulates apoptosis, migration, and invasion of ovarian cancer cells via mediating RECK.
Zheng J; Li X; Yang W; Zhang F
J Pharmacol Sci; 2021 Jun; 146(2):71-81. PubMed ID: 33941323
[TBL] [Abstract][Full Text] [Related]
3. Dihydroartemisinin inhibits the tumorigenesis and metastasis of breast cancer via downregulating CIZ1 expression associated with TGF-β1 signaling.
Li Y; Zhou X; Liu J; Gao N; Yang R; Wang Q; Ji J; Ma L; He Q
Life Sci; 2020 May; 248():117454. PubMed ID: 32088211
[TBL] [Abstract][Full Text] [Related]
4. Dihydroartiminisin inhibits the growth and metastasis of epithelial ovarian cancer.
Wu B; Hu K; Li S; Zhu J; Gu L; Shen H; Hambly BD; Bao S; Di W
Oncol Rep; 2012 Jan; 27(1):101-8. PubMed ID: 22025319
[TBL] [Abstract][Full Text] [Related]
5. Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/KDR/MMP9 and P53/BCL2L1/CASP3/7 pathways.
Liang R; Chen W; Chen XY; Fan HN; Zhang J; Zhu JS
Pathol Res Pract; 2021 Feb; 218():153318. PubMed ID: 33370709
[TBL] [Abstract][Full Text] [Related]
6. Dihydroartemisinin suppresses glioma proliferation and invasion via inhibition of the ADAM17 pathway.
Chen J; Chen X; Wang F; Gao H; Hu W
Neurol Sci; 2015 Mar; 36(3):435-40. PubMed ID: 25301262
[TBL] [Abstract][Full Text] [Related]
7. Anticancer effects of α-mangostin in OVACAR-3 human ovarian carcinoma cells are mediated via involvement of reactive oxygen species, mitochondrial -mediated apoptosis, suppression of cell migration and invasion and m-TOR/PI3K/AKT signaling pathway.
Yu Y; Fei Z; Qin L
J BUON; 2020; 25(5):2293-2300. PubMed ID: 33277848
[TBL] [Abstract][Full Text] [Related]
8. The Effect of Dihydroartemisinin on the Malignancy and Epithelial-Mesenchymal Transition of Gastric Cancer Cells.
Li N; Zhang S; Luo Q; Yuan F; Feng R; Chen X; Yang S
Curr Pharm Biotechnol; 2019; 20(9):719-726. PubMed ID: 31187708
[TBL] [Abstract][Full Text] [Related]
9. Dihydroartemisinin inhibits the growth and invasion of gastric cancer cells by regulating cyclin D1-CDK4-Rb signaling.
Fan HN; Zhu MY; Peng SQ; Zhu JS; Zhang J; Qu GQ
Pathol Res Pract; 2020 Feb; 216(2):152795. PubMed ID: 31879047
[TBL] [Abstract][Full Text] [Related]
10. Dihydroartemisinin and gefitinib synergistically inhibit NSCLC cell growth and promote apoptosis via the Akt/mTOR/STAT3 pathway.
Jin H; Jiang AY; Wang H; Cao Y; Wu Y; Jiang XF
Mol Med Rep; 2017 Sep; 16(3):3475-3481. PubMed ID: 28713965
[TBL] [Abstract][Full Text] [Related]
11. [Effects of dihydroartiminisin on the adhesion, migration, and invasion of epithelial ovarian cancer cells].
Tan XJ; Lang JH; Plouet J; Wu M; Shen K
Zhonghua Yi Xue Za Zhi; 2008 Oct; 88(37):2642-6. PubMed ID: 19080714
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of Gli transcription factor leads to the inhibition of migration and invasion of ovarian cancer cells via integrin β4-mediated FAK signaling.
Chen Q; Xu R; Zeng C; Lu Q; Huang D; Shi C; Zhang W; Deng L; Yan R; Rao H; Gao G; Luo S
PLoS One; 2014; 9(2):e88386. PubMed ID: 24533083
[TBL] [Abstract][Full Text] [Related]
13. Naturally occurring davanone terpenoid exhibits anticancer potential against ovarian cancer cells by inducing programmed cell death, by inducing caspase-dependent apoptosis, loss of mitochondrial membrane potential, inhibition of cell migration and invasion and targeting PI3K/AKT/MAPK signaling pathway.
Cai J; Zhong YY; Tian S
J BUON; 2020; 25(5):2301-2307. PubMed ID: 33277849
[TBL] [Abstract][Full Text] [Related]
14. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
Li W; Cao L; Chen X; Lei J; Ma Q
Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
[TBL] [Abstract][Full Text] [Related]
16. Artemisinin derivatives inhibit epithelial ovarian cancer cells via autophagy-mediated cell cycle arrest.
Li B; Bu S; Sun J; Guo Y; Lai D
Acta Biochim Biophys Sin (Shanghai); 2018 Dec; 50(12):1227-1235. PubMed ID: 30395153
[TBL] [Abstract][Full Text] [Related]
17. Gli affects the stemness and prognosis of epithelial ovarian cancer via homeobox protein NANOG.
Zhao H; Li N; Pang Y; Zhao J; Wu X
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313950
[TBL] [Abstract][Full Text] [Related]
18. Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it's inhibition leads to growth suppression and apoptosis.
Chen X; Horiuchi A; Kikuchi N; Osada R; Yoshida J; Shiozawa T; Konishi I
Cancer Sci; 2007 Jan; 98(1):68-76. PubMed ID: 17083567
[TBL] [Abstract][Full Text] [Related]
19. Preclinical Efficacy and Safety Assessment of Artemisinin-Chemotherapeutic Agent Conjugates for Ovarian Cancer.
Li X; Zhou Y; Liu Y; Zhang X; Chen T; Chen K; Ba Q; Li J; Liu H; Wang H
EBioMedicine; 2016 Dec; 14():44-54. PubMed ID: 27939426
[TBL] [Abstract][Full Text] [Related]
20. Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation.
Liao X; Siu MK; Au CW; Wong ES; Chan HY; Ip PP; Ngan HY; Cheung AN
Carcinogenesis; 2009 Jan; 30(1):131-40. PubMed ID: 19028702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
